Tag: Sexually Transmitted Diseases: AIDS/HIV
Adding Maraviroc to c-ART No Better in Advanced HIV
Incidence of severe morbidity similar for addition of maraviroc versus placebo to standard c-ART
Costs of ART Regimens Increasing, Outpacing Inflation
Annual average wholesale price of initial ART regimens recommended for most persons with HIV >$36,000
January 2020 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for January 2020. This roundup includes...
HIV Vaccine Ineffective, Clinical Trial Halted
NIH-sponsored trial was being conducted in South Africa
CDC: HIV-1/HIV-2 Differentiation Test Increasingly Used in U.S.
Number of HIV-2 diagnoses remains low; more false positives seen with greater use of differentiation test
Neural Tube Defect Prevalence 7.0 Per 10,000 in HIV-Exposed
Prevalence of 7.0 per 10,000 HIV-exposed pregnancies similar to prevalence in general population
Early Antiretroviral Therapy May Not Achieve HIV Remission in Infants
Similar proportion of infants attain, sustain viral suppression when starting <48 hours, two to 14 days after birth
HIV+ Patients Lose Immunity to Smallpox Despite Vaccination
Among HIV+ patients, there was a significant loss in vaccinia-specific CD4+ T cell memory
December 2019 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for December 2019. This roundup includes...
Nurses Can Help Manage Drug Interactions in HIV/Hep C Treatment
Administration of simeprevir is more problematic with ART; sofosbuvir has fewest interactions with ART
